Australia markets closed

Beijing Balance Medical Technology Co.,Ltd. (688198.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
124.70-0.19 (-0.15%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 17.03B
Enterprise value 16.56B
Trailing P/E 161.95
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)51.61
Price/book (mrq)14.73
Enterprise value/revenue 49.91
Enterprise value/EBITDA 147.82

Trading information

Stock price history

Beta (5Y monthly) 0.69
52-week change 3-7.70%
S&P500 52-week change 325.88%
52-week high 3144.00
52-week low 397.51
50-day moving average 3116.80
200-day moving average 3122.00

Share statistics

Avg vol (3-month) 3333.19k
Avg vol (10-day) 3383.68k
Shares outstanding 5136.58M
Implied shares outstanding 6136.58M
Float 835.39M
% held by insiders 173.78%
% held by institutions 110.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 40.40%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 30.40%
5-year average dividend yield 4N/A
Payout ratio 464.94%
Dividend date 3N/A
Ex-dividend date 425 May 2023
Last split factor 21.4:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 31.83%
Operating margin (ttm)29.24%

Management effectiveness

Return on assets (ttm)4.54%
Return on equity (ttm)9.39%

Income statement

Revenue (ttm)331.82M
Revenue per share (ttm)2.45
Quarterly revenue growth (yoy)12.50%
Gross profit (ttm)N/A
EBITDA 91.08M
Net income avi to common (ttm)105.63M
Diluted EPS (ttm)0.78
Quarterly earnings growth (yoy)15.80%

Balance sheet

Total cash (mrq)484.82M
Total cash per share (mrq)3.55
Total debt (mrq)13.38M
Total debt/equity (mrq)1.16%
Current ratio (mrq)13.48
Book value per share (mrq)8.46

Cash flow statement

Operating cash flow (ttm)137.08M
Levered free cash flow (ttm)-150.06M